Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -4.17% 5.75p 5.50p 6.00p 6.00p 5.75p 6.00p 247,342 08:12:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 4.30

N4 Pharma Share Discussion Threads

Showing 601 to 623 of 625 messages
Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older
DateSubjectAuthorDiscuss
23/8/2017
19:29
If this drops to 5.75p on the offer I'm having a load more.Worth taking a gander at OPTI folks.
parob
23/8/2017
14:36
I see that Flexton has been outed as the troll Slopjockey who posts on lse about n4p. Both Flexton and Slopjockey have said that they would stop posting comments on n4p but just can't help himself. Obviously someone with a personal grudge about n4p.
square root
16/8/2017
10:13
Will TEVA be interested?
flexton
16/8/2017
10:11
Serious question: Who do you see N4P licensing the IP to? Cheers.
flexton
16/8/2017
10:10
How's that sustained rise going for you whl2? "Lifestyle drugs like Viagra and Cialis have been an extraordinary success for drug companies for many years. It will be difficult to replace the revenue of these blockbuster drugs once they go off patent in the United States, but when that happens consumers can expect generics to race into the marketplace and for prices to fall". - Angélique McCall (IPwatchdog) A quick question. When all the generic versions come on to the market who will N4P license their IP to? Will it be Teva or multiple companies. Say you had ED yourself, and the NHS or your Insurance Company said "listen, we won't fund lifestyle drugs any longer. You'll have to pay for it yourself". What would you choose: a. Fast acting - 15 minutes- but costs more. b. Generic version - 30-60 minutes - but costs less. You can see the dilemma can't you? Where's the revenue going to be made? Show me the money.
flexton
11/8/2017
10:18
IG not allowing you to open new positions - only closing positions allowed presently. Expecting more upside today and next week.
whl2
10/8/2017
18:44
A nice start to the recovery and long may it continue. Still a long way to go yet. Well done to all those who got themselves a low price top-up on the crazy drop we've seen here. Plenty more upside to go yet.
bdog51
10/8/2017
18:39
Had a couple of top ups under 6.5p this morning. Nice 270K buy now showing from 4pm. Some good momentum and feels like it's got much further to go.
parob
10/8/2017
17:44
whl222It went where it was needed. Below IPO. It's still not a long term hold.. yet.
backtogo
10/8/2017
14:59
Took some stock today.
ultra capital
10/8/2017
13:38
Not long now guys, back to re-test the previous highs before year-end IMHO
trotterstrading
10/8/2017
12:53
It looks like the share overhang which has been depressing the shares has finally been absorbed. I expect even modest buying from here will propel the shares back up.
biggest bill
10/8/2017
12:49
Someone has!!!
moormoney
10/8/2017
12:40
Notice the bear posts dried up the last few days - you all been buying!
whl2
09/8/2017
11:15
700k buy - explains the rise yesterday, not mine by the way :{
whl2
07/8/2017
14:15
Cheers Square Root. Did I mention #Iron? Do yourselves a favour and bag a load of them . Take the profit and come back for N4P. Time is on your side, guys. DYOR
flexton
07/8/2017
09:32
Flexton, keep your word and stop posting.
square root
06/8/2017
20:51
Key facts - Packages start at $500 per treatment.Typically 6 to 12 treatments are recommended Data from randomized trials are conflicting, and many questions remain to be answered before we can routinely offer this treatment to patients. This treatment has been around and known about for ~5 Yrs Another deramp bites the dust
zebbo
06/8/2017
12:50
I know I wasn't going to post again until the placing but I've just been researching reasons why the share price may have fallen at the back end of July and at the beginning of August. Did anyone take note of the news coming out about Li-ESWT and Gainswave? I'll be honest, I didn't. From the Med Pub: "Several single-arm trials have shown benefit of Li-ESWT on patient-reported erectile function scores, but data from randomized trials are conflicting, and many questions remain to be answered before we can routinely offer this treatment to patients. Thus, the search for the true clinical value of Li-ESWT for ED represents a dynamic and continuing field of enquiry". Gainswave is now being offered to treat ED. The race is on! Let's hope N4P can pull it out of the bag. Happy Sunday. Good luck for next week.
flexton
04/8/2017
00:46
I dont think a lot of people are listening Flexton. This is listed on aim i believe , no more than a casino. No one is really believes anything people say. This is just playing at a roulette wheel No one cares if you are right or wrong, so dont come back and admit if you are wrong.no need. Spin the wheel guys!
escapetohome
03/8/2017
23:24
Good riddance flexton....
zebbo
03/8/2017
16:35
Guys, I'll let you crack on. It's pointless writing on here. That said I'll come back after the placing I think is going to happen (IMHO) and see where the share price is. I'll be the first person to put my hands up and say I called it wrong. Good luck all, I hope we all make a lot of money. Ps. #Ironveld ;-)
flexton
03/8/2017
16:30
Bill, I was going to explain the edit to you.....but I guess you won't see it now. Edit: One edit was because I incorrectly read and referred to you as Buffalo Bill. The other edit was due to a spelling mistake. Simple as that.
flexton
Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20170824 03:10:42